ACIU — AC Immune SA Share News
0.000.00%
Last trade - 00:00- $260.54m
- $173.47m
- CH₣3.57m
U.S. STOCKS ON THE MOVE-Annexon, MKS Instruments, Robinhood
AC Immune SA reports results for the quarter ended in March - Earnings Summary
U.S. STOCKS ON THE MOVE-GameStop, AC Immune , Fulcrum Therapeutics
AC Immune jumps on licensing deal with Takeda for Alzheimer's disease treatment
Brief: Ac Immune And Takeda Sign Exclusive Option And License Agreement For Active Immunotherapy
AC Immune SA expected to post a loss of 14 rappen a share - Earnings Preview
AC Immune SA expected to post a loss of 14 rappen a share - Earnings Preview
AC Immune SA reports results for the quarter ended in December - Earnings Summary
AC Immune SA expected to post a loss of 11 rappen a share - Earnings Preview
Brief: AC Immune To Regain Global Rights To Crenezumab And Semorinemab
Brief: Ac Immune Progress Update On Phase 2 Active Immunotherapy Clinical Pipeline
Brief: AC Immune Priced An Underwritten Offering Of 14.3 Million Of Shares At $3.50 Per Share
Brief: AC Immune’s Targeted Anti-pTau Active Immunotherapy For Alzheimer’s Disease Advances Into Phase 2B Trial
Focus: Researchers return to Alzheimer's vaccines, buoyed by recent drug success
AC Immune SA reports results for the quarter ended in September - Earnings Summary
Brief: AC Immune Q3 EPS CHF -0.18
AC Immune SA expected to post earnings of 3 rappen a share - Earnings Preview
AC Immune SA reports results for the quarter ended in June - Earnings Summary
Brief: AC Immune Appoints New Chief Medical Officer